SCHEMBL25668643

SCHEMBL25668643

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3cccc4c(-c5cccc6ccccc56)cccc34)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ ATM Q13315 3/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22026340 0.99 KDM4E (0.47) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943455 0.97 KDM4E (0.46) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943606 0.94 KDM4E (0.44) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL19276001 0.93 KDM4E (0.47) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL21448347 0.92 KDM4E (0.41) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943382 0.92 KDM4E (0.46) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL25605613 0.91 KDM4E (0.41) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL25668641 0.91 KDM4E (0.44) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL25726596 0.91 KDM4E (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL22596088 0.90 KDM4E (0.43) KDM4EATML3MBTL1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 KDM4E 4378/4885ATM 3631/4885L3MBTL1 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback